• Alakunle, E., Kolawole, D., Diaz-Canova, D., Alele, F., Adegboye, O., Moens, U., Okeke, M.I., 2024. A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol 14, 1360586.

  • Alakunle, E., Moens, U., Nchinda, G., Okeke, M.I., 2020. Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses 12, 1257.

  • Allison, A.C., 2005. Mechanisms of action of mycophenolate mofetil. Lupus 14 Suppl 1, s2-8.

  • Andrei, G., Snoeck, R., 2023. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Trends Pharmacol Sci 44, 719-739.

  • Andrei, G., Snoeck, R., 2023. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Trends Pharmacol Sci 44, 719-739.

  • Burrell, A.L., Kollman, J.M., 2022. IMPDH dysregulation in disease: a mini review. Biochem Soc Trans 50, 71-82.

  • Calise, S.J., Chan, E.K.L., 2020. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery. Autoimmun Rev 19, 102643.

  • Carcamo, W.C., Satoh, M., Kasahara, H., Terada, N., Hamazaki, T., Chan, J.Y., Yao, B., Tamayo, S., Covini, G., von Muhlen, C.A., Chan, E.K., 2011. Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells. PLoS One 6, e29690.

  • Castaneda Catana, M.A., Rivas Marquina, A.P., Dodes Traian, M.M., Carlucci, M.J., Damonte, E.B., Perez, O.E., Arrua, E.C., Sepulveda, C.S., 2025. Bovine Serum Albumin Nanoparticle-Mediated Delivery of Ribavirin and Mycophenolic Acid for Enhanced Antiviral Therapeutics. Viruses 17, 138.

  • Chen, C.Y., Chen, C.L., Ng, Y.S., Lee, D.Y., Lin, S.S., Huang, C.K., Kumar, R., Wang, H.C., 2025. Glucose- and glutamine-driven de novo nucleotide synthesis facilitates WSSV replication in shrimp. Cell Commun Signal 23, 191.

  • Cho, J., Yi, H., Jang, E.Y., Lee, M.S., Lee, J.Y., Kang, C., Lee, C.H., Kim, K., 2017. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection. Biochem Biophys Res Commun 494, 298-304.

  • Dsouza, L., Pant, A., Offei, S., Priyamvada, L., Pope, B., Satheshkumar, P.S., Wang, Z., Yang, Z., 2023. Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts. Antiviral Res 216, 105651.

  • Dsouza, L., Yang, Z., 2025. Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection. J Med Virol 97, e70563.

  • Frenois-Veyrat, G., Gallardo, F., Gorge, O., Marcheteau, E., Ferraris, O., Baidaliuk, A., Favier, A.L., Enfroy, C., Holy, X., Lourenco, J., Khoury, R., Nolent, F., Grosenbach, D.W., Hruby, D.E., Ferrier, A., Iseni, F., Simon-Loriere, E., Tournier, J.N., 2022. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations. Nat Microbiol 7, 1951-1955.

  • Gedeon, A., Ayoub, N., Brule, S., Raynal, B., Karimova, G., Gelin, M., Mechaly, A., Haouz, A., Labesse, G., Munier-Lehmann, H., 2023. Insight into the role of the Bateman domain at the molecular and physiological levels through engineered IMP dehydrogenases. Protein Sci 32, e4703.

  • Harapan, H., Ophinni, Y., Megawati, D., Frediansyah, A., Mamada, S.S., Salampe, M., Bin Emran, T., Winardi, W., Fathima, R., Sirinam, S., Sittikul, P., Stoian, A.M., Nainu, F., Sallam, M., 2022. Monkeypox: A Comprehensive Review. Viruses 14, 2155.

  • Hart, B.J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R.F., Olinger, G.G., Frieman, M.B., Holbrook, M.R., Jahrling, P.B., Hensley, L., 2014. Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol 95, 571-577.

  • Hisam, F., Winn, E., Mukherjee, S., Price, S., Gaspar, Y.A., Wang, C., Baniasadi, H.R., Delgado, T., Sanchez, E.L., 2026. Global Metabolomic Analysis of Lytic KSHV Infection: Induced Host Nucleotide Metabolism is Required for Infectious Virus Production. bioRxiv. doi:10.64898/2026.02.02.703314.

  • Hu, H., Wang, Q., Ai, Q., Zhou, P., He, Y., Ye, Z., Ma, K., Zhou, M., Huang, S., Wang, L., Qi, N., Xiao, G., Wang, S., 2026. FDA-approved IMPDH inhibitors synergize with ribavirin to inhibit respiratory syncytial virus by interfering with purine de novo synthesis. Emerg Microbes Infect 15, 2640289.

  • Jiang, S., Jiang, L., Xu, Y., Ma, Y., Deng, Y., Jiao, C., Yin, M., Qin, C., Li, J., Zhang, L., Chen, S., 2025. USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression. Oncogene 44, 1936-1948.

  • Ju, B., Liu, C., Zhang, J., Li, Y., Yang, H., Zhou, B., Huang, B., Ma, J., Lu, J., Cheng, L., Cong, Z., Zhu, L., Shi, T., Sun, Y., Li, N., Chen, T., Wang, M., Tang, S., Ge, X., Zhao, J., Tan, W.J., Yan, R., Xue, J., Zhang, Z., 2025. Structurally conserved human anti-A35 antibodies protect mice and macaques from mpox virus infection. Cell 188, 6253-6265.e6214.

  • Keppeke, G.D., Calise, S.J., Chan, E.K.L., Andrade, L.E.C., 2019. Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs. Antiviral Res 162, 130-135.

  • Li, H., Huang, Q.Z., Zhang, H., Liu, Z.X., Chen, X.H., Ye, L.L., Luo, Y., 2023. The land-scape of immune response to monkeypox virus. EBioMedicine 87, 104424.

  • Lim, C.K., Roberts, J., Moso, M., Liew, K.C., Taouk, M.L., Williams, E., Tran, T., Steinig, E., Caly, L., Williamson, D.A., 2023. Mpox diagnostics: Review of current and emerging technologies. J Med Virol 95, e28429.

  • Luo, P., Liu, D., Zhang, Q., Yang, F., Wong, Y.K., Xia, F., Zhang, J., Chen, J., Tian, Y., Yang, C., Dai, L., Shen, H.M., Wang, J., 2022. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B 12, 2300-2314.

  • MacIntyre, C.R., de Sousa, J.C., Heininger, U., Kardos, P., Konstantopoulos, A., Middleton, D., Nolan, T., Papi, A., Rendon, A., Rizzo, A., Sampson, K., Sette, A., Sobczyk, E., Tan, T., Weil-Olivier, C., Weinberger, B., Wilkinson, T., von Konig, C.H.W., 2024. Public health management of pertussis in adults: Practical challenges and future strategies. Hum Vaccin Immunother 20, 2377904.

  • Manchala, N.R., Dungdung, R., Trivedi, P., Unniyampurath, U., Pilankatta, R., 2019. Mycophenolic acid (MPA) modulates host cellular autophagy progression in sub genomic dengue virus-2 replicon cells. Microb Pathog 137, 103762.

  • Mitja, O., Ogoina, D., Titanji, B.K., Galvan, C., Muyembe, J.J., Marks, M., Orkin, C.M., 2023. Monkeypox. Lancet 401, 60-74.

  • Nass, K., Redecke, L., Perbandt, M., Yefanov, O., Klinge, M., Koopmann, R., Stellato, F., Gabdulkhakov, A., Schonherr, R., Rehders, D., Lahey-Rudolph, J.M., Aquila, A., Barty, A., Basu, S., Doak, R.B., Duden, R., Frank, M., Fromme, R., Kassemeyer, S., Katona, G., Kirian, R., Liu, H., Majoul, I., Martin-Garcia, J.M., Messerschmidt, M., Shoeman, R.L., Weierstall, U., Westenhoff, S., White, T.A., Williams, G.J., Yoon, C.H., Zatsepin, N., Fromme, P., Duszenko, M., Chapman, H.N., Betzel, C., 2020. In cellulo crystallization of Trypanosoma brucei IMP dehydrogenase enables the identification of genuine co-factors. Nat Commun 11, 620.

  • Nuzzo, J.B., Borio, L.L., Gostin, L.O., 2022. The WHO Declaration of Monkeypox as a Global Public Health Emergency. Jama 328, 615-617.

  • Ogawa-Iio, A., Takeuchi, K., Shigemi, K., Genoveso, M.J., Niitsu, H., Koh, I., Ota, Y., Yamane, K., Hinoi, T., Osaka, N., Oshima, M., Ishikawa, T., Mizuno, T., Natsumeda, M., Tateishi, K., Hashizume, R., Osuka, S., Goyama, S., Yasuda, T., Senda, T., Sasaki, A.T., 2025. IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope. Cancer Sci 116, 3250-3265.

  • Ortiz-Saavedra, B., Leon-Figueroa, D.A., Montes-Madariaga, E.S., Ricardo-Martinez, A., Alva, N., Cabanillas-Ramirez, C., Barboza, J.J., Siddiq, A., Coaguila Cusicanqui, L.A., Bonilla-Aldana, D.K., Rodriguez-Morales, A.J., 2022. Antiviral Treatment against Monkeypox: A Scoping Review. Trop Med Infect Dis 7, 369.

  • Poland, G.A., Kennedy, R.B., Tosh, P.K., 2022. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis 22, e349-e358.

  • Qiao, Z., Li, D., Zhang, F., Zhu, J., Liu, S., Bai, X., Yao, H., Chen, Z., Yan, Y., Xu, X., Ma, F., 2025. USP5 inhibits anti-RNA viral innate immunity by deconjugating K48-linked unanchored and K63-linked anchored ubiquitin on IRF3. PLoS Pathog 21, e1012843.

  • Rizk, Y., Lippi, G., Henry, B.M., Notarte, K.I., Rizk, J.G., 2025. Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes. Drugs 85, 1-9.

  • Shand, E.L., Sweeney, K., Sundling, K.E., McClean, M.N., Brow, D.A., 2024. Live-cell analysis of IMPDH protein levels during yeast colony growth provides insights into the regulation of GTP synthesis. mBio 15, e0102124.

  • Shchelkunova, G.A., Shchelkunov, S.N., 2022. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections. Viruses 15, 103.

  • Shen, Y., Li, Y., Yan, R., 2024. Structural basis for the inhibition mechanism of the DNA polymerase holoenzyme from mpox virus. Structure 32, 654-661.e653.

  • Siegrist, E.A., Sassine, J., 2023. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Clin Infect Dis 76, 155-164.

  • Smith, T.G., Gigante, C.M., Wynn, N.T., Matheny, A., Davidson, W., Yang, Y., Condori, R.E., O'Connell, K., Kovar, L., Williams, T.L., Yu, Y.C., Petersen, B.W., Baird, N., Lowe, D., Li, Y., Satheshkumar, P.S., Hutson, C.L., 2023. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023. Emerg Infect Dis 29, 2426-2432.

  • Tang, N., Chen, P., Zhao, C., Liu, P., Tan, L., Song, C., Qiu, X., Liao, Y., Liu, X., Luo, T., Sun, Y., Ding, C., 2023. Newcastle Disease Virus Manipulates Mitochondrial MTHFD2-Mediated Nucleotide Metabolism for Virus Replication. J Virol 97, e0001623.

  • Tu, Y., Tan, L., Tao, H., Li, Y., Liu, H., 2023. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. Phytomedicine 116, 154862.

  • Vernuccio, R., Martinez Leon, A., Poojari, C.S., Buchrieser, J., Selverian, C.N., Jaleta, Y., Meola, A., Guivel-Benhassine, F., Porrot, F., Haouz, A., Chevreuil, M., Raynal, B., Mercer, J., Simon-Loriere, E., Chandran, K., Schwartz, O., Hub, J.S., Guardado-Calvo, P., 2025. Structural insights into tecovirimat antiviral activity and poxvirus resistance. Nat Microbiol 10, 734-748.

  • Wan, Q., Tavakoli, L., Wang, T.Y., Tucker, A.J., Zhou, R., Liu, Q., Feng, S., Choi, D., He, Z., Gack, M.U., Zhao, J., 2024. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus. Nat Commun 15, 1442.

  • Wu, M., Wang, K., Wang, H., Yan, H., Wu, S., Yang, G., Li, Y., Che, Y., Jiang, J., 2025. Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2. Virol J 22, 56.

  • Yuan, L., Wang, M., Zhang, X., Wang, Z., 2017. Effects of protease and non-starch polysaccharide enzyme on performance, digestive function, activity and gene expression of endogenous enzyme of broilers. PLoS One 12, e0173941.

  • Zhou, S., Zhao, H., Zhu, J., Zhou, Y., Yang, Z., Wang, Z., 2026. Porcine epidemic diarrhea virus manipulates IMPDH-dependent nucleotide biosynthesis to facilitate replication. J Virol 100, e0173625.

  • Zhu, J., Gao, X., Li, Y., Zhang, Z., Xie, S., Ren, S., Li, Y., Li, H., Niu, K., Fu, S., Deng, Y., Li, Y., Moss, B., Wu, W., Peng, C., 2023. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1. Proc Natl Acad Sci U S A 120, e2304242120.